Mari Takamiya

469 total citations
13 papers, 406 citations indexed

About

Mari Takamiya is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Mari Takamiya has authored 13 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 5 papers in Oncology. Recurrent topics in Mari Takamiya's work include Neuropeptides and Animal Physiology (6 papers), Peptidase Inhibition and Analysis (4 papers) and Receptor Mechanisms and Signaling (4 papers). Mari Takamiya is often cited by papers focused on Neuropeptides and Animal Physiology (6 papers), Peptidase Inhibition and Analysis (4 papers) and Receptor Mechanisms and Signaling (4 papers). Mari Takamiya collaborates with scholars based in Japan, Switzerland and United States. Mari Takamiya's co-authors include Mikio Arisawa, Yukio Umeda, Takafumi Uchida, Fumihiro Fujimori, Mikako Shirouzu, Tony Hunter, Hitoshi Miyashita, Shigeyuki Yokoyama, Yo Matsuo and Toshikazu Okada and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Neuroscience Letters and Peptides.

In The Last Decade

Mari Takamiya

13 papers receiving 394 citations

Peers

Mari Takamiya
Derek McCulloch Australia
Frederick J. Darfler United States
Karissa Gable United States
Paola Rojas Argentina
Mark P. Baganoff United States
Valerie J. Horn United States
Irene Gall United Kingdom
Derek McCulloch Australia
Mari Takamiya
Citations per year, relative to Mari Takamiya Mari Takamiya (= 1×) peers Derek McCulloch

Countries citing papers authored by Mari Takamiya

Since Specialization
Citations

This map shows the geographic impact of Mari Takamiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mari Takamiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mari Takamiya more than expected).

Fields of papers citing papers by Mari Takamiya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mari Takamiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mari Takamiya. The network helps show where Mari Takamiya may publish in the future.

Co-authorship network of co-authors of Mari Takamiya

This figure shows the co-authorship network connecting the top 25 collaborators of Mari Takamiya. A scholar is included among the top collaborators of Mari Takamiya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mari Takamiya. Mari Takamiya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Takamiya, Mari, et al.. (2016). Lead discovery for mammalian elongation of long chain fatty acids family 6 using a combination of high-throughput fluorescent-based assay and RapidFire mass spectrometry assay. Biochemical and Biophysical Research Communications. 480(4). 721–726. 8 indexed citations
2.
Mori, Tadashi, Masafumi Hidaka, Yi‐Chin Lin, et al.. (2011). A dual inhibitor against prolyl isomerase Pin1 and cyclophilin discovered by a novel real-time fluorescence detection method. Biochemical and Biophysical Research Communications. 406(3). 439–443. 33 indexed citations
3.
Mori, Tadashi, et al.. (2009). Use of a Real-Time Fluorescence Monitoring System for High-Throughput Screening for Prolyl Isomerase Inhibitors. SLAS DISCOVERY. 14(4). 419–424. 17 indexed citations
4.
Uchida, Takafumi, Mari Takamiya, Hitoshi Miyashita, et al.. (2003). Pin1 and Par14 Peptidyl Prolyl Isomerase Inhibitors Block Cell Proliferation. Chemistry & Biology. 10(1). 15–24. 149 indexed citations
5.
Nagase, Hiromi, et al.. (1993). Activation of CCK-B receptors elevates cytosolic Ca2+ levels in a pituitary cell line. Peptides. 14(4). 801–805. 13 indexed citations
6.
Nakano, Atsuko, et al.. (1993). Species specificity of pharmacological characteristics of CCK-B receptors. Neuroscience Letters. 158(1). 1–4. 14 indexed citations
7.
Takamiya, Mari, et al.. (1993). GH3 cells, an anterior pituitary cell line, express CCK-B receptors. Peptides. 14(3). 647–649. 7 indexed citations
8.
Nagase, Hiromi, et al.. (1991). Effect of cholecystokinin-8 on the intracellular Ca2+ concentration in GH3, a rat anterior pituitary tumor cell line.. The Japanese Journal of Pharmacology. 55. 115–115. 8 indexed citations
9.
Takamiya, Mari, et al.. (1991). The presence of cholecystokinin B receptors in rat pituitary gland and GH3, a rat anterior pituitary tumor cell line.. The Japanese Journal of Pharmacology. 55. 355–355. 4 indexed citations
10.
Umeda, Yukio, et al.. (1988). Inhibition of mitogen-stimulated T lymphocyte proliferation by calcitonin gene-related peptide. Biochemical and Biophysical Research Communications. 154(1). 227–235. 112 indexed citations
11.
Nakamura, Yoshiyuki, Kazuo Nakamura, Mari Takamiya, & Keiji Nakamura. (1987). Vascular angiotensin converting enzyme (ACE) activity and cilazapril in SHR. The Japanese Journal of Pharmacology. 43. 143–143. 3 indexed citations
13.
Takamiya, Mari, et al.. (1987). Characterization of picomolar affinity binding sites for [125I]-human calcitonin gene-related peptide in rat brain and heart. Biochemical and Biophysical Research Communications. 146(2). 443–451. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026